And it actually, earlier this week expanded the number of vials it offers
Lithium neuroprotection: molecular mechanisms and clinical implications
Additional studies could be directed toward optimizing delivery techniques, dosing schedules, product stability, and intranasal formulations
The truth lies between the myths and the facts
Product information What you are ordering BPC-157 research compound Single 10mg vial format Laboratory peptide supply Research context Before you order Common questions No
TLDR: "Discontinuation of GLP-1RA treatment leads to weight regain, regardless of lifestyle interventions, and should therefore be considered a chronic therapy to prevent weight regain and associated undesirable outcomes related to obesity." Key findings: After stopping liraglutide, patients regained ~2.2 kg After stopping semaglutide/tirzepatide, patients regained ~9.7 kg Weight regain was proportional to initial weight loss Lifestyle changes alone DID NOT prevent regain Implication: GLP-1 receptor agonists are not a short-term solution